DELAVIRDINE MESYLATE
Modify Date: 2024-01-08 17:15:34
DELAVIRDINE MESYLATE structure
|
Common Name | DELAVIRDINE MESYLATE | ||
|---|---|---|---|---|
| CAS Number | 147221-93-0 | Molecular Weight | 552.667 | |
| Density | N/A | Boiling Point | 732ºC at 760mmHg | |
| Molecular Formula | C23H32N6O6S2 | Melting Point | 118-120ºC | |
| MSDS | Chinese USA | Flash Point | 396.5ºC | |
Use of DELAVIRDINE MESYLATEDelavirdine mesylate is a potent non-nucleoside HIV-1 reverse transcriptase inhibitor (NNRTI) of HIV-1. |
| Name | delavirdine mesylate |
|---|---|
| Synonym | More Synonyms |
| Description | Delavirdine mesylate is a potent non-nucleoside HIV-1 reverse transcriptase inhibitor (NNRTI) of HIV-1. |
|---|---|
| Related Catalog | |
| References |
| Boiling Point | 732ºC at 760mmHg |
|---|---|
| Melting Point | 118-120ºC |
| Molecular Formula | C23H32N6O6S2 |
| Molecular Weight | 552.667 |
| Flash Point | 396.5ºC |
| Exact Mass | 552.182495 |
| PSA | 181.56000 |
| LogP | 4.53160 |
| Vapour Pressure | 2.74E-21mmHg at 25°C |
| Storage condition | 2-8℃ |
| RIDADR | NONH for all modes of transport |
|---|
|
Colloid formation by drugs in simulated intestinal fluid.
J. Med. Chem. 53 , 4259-65, (2010) Many organic molecules form colloidal aggregates in aqueous solution at micromolar concentrations. These aggregates promiscuously inhibit soluble proteins and are a major source of false positives in ... |
|
|
Methylmethacrylate–sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood–brain barrier
Colloids Surf. B Biointerfaces 90 , 75-82, (2012) Graphical abstract |
|
|
Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs.
Bioorg. Med. Chem. 21(7) , 2128-34, (2013) In continuation of our efforts toward identification and optimization of novel non-nucleoside reverse transcriptase inhibitors (NNRTIs), we have employed a structure-based bioisosterism strategy, with... |
| DELAVIRDINE, MESYLATE |
| N-{2-[(4-{3-[(1-methylethyl)amino]pyridin-2-yl}piperazin-1-yl)carbonyl]-1H-indol-5-yl}methanesulfonamide methanesulfonate |
| N-[2-({4-[3-(Isopropylamino)pyridin-2-yl]piperazin-1-yl}carbonyl)-1H-indol-5-yl]methanesulfonamide methanesulfonate (1:1) |
| Methanesulfonamide, N-[2-[[4-[3-[(1-methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]-, methanesulfonate (1:1) |
| 1-(3-(Isopropylamino)-2-pyridyl)-4-((5-methanesulfonamidoindol-2-yl)carbonyl)piperazine monomethanesulfonate |
| acide méthanesulfonique - N-{2-[(4-{3-[(1-méthyléthyl)amino]pyridin-2-yl}pipérazin-1-yl)carbonyl]-1H-indol-5-yl}méthanesulfonamide (1:1) |
| delavirdine mesilate [INN_en] |
| piperazine, 1-[3-[(1-methylethyl)amino]-2-pyridinyl]-4-[[5-[(methylsulfonyl)amino]-1H-indol-2-yl]carbonyl]-, methanesulfonate (1:1) |
| N-[2-({4-[3-(Isopropylamino)-2-pyridinyl]-1-piperazinyl}carbonyl)-1H-indol-5-yl]methanesulfonamide methanesulfonate (1:1) |
| DELAVIRDINE MESYLATE |
| Piperazine, 1-(3-((1-methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)-, monomethanesulfonate |
| Delavirdine monomethanesulfonate |
| Methansulfonsäure--N-{2-[(4-{3-[(1-methylethyl)amino]pyridin-2-yl}piperazin-1-yl)carbonyl]-1H-indol-5-yl}methansulfonamid(1:1) |
| N-[2-({4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl}carbonyl)-1H-indol-5-yl]methanesulfonamide methanesulfonate (1:1) |
| Delavirdine (mesylate) |